286 related articles for article (PubMed ID: 26305706)
1. Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.
Scott N; Hellard M; McBryde ES
Virulence; 2016; 7(2):201-8. PubMed ID: 26305706
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C transmission and treatment as prevention - The role of the injecting network.
Hellard M; McBryde E; Sacks Davis R; Rolls DA; Higgs P; Aitken C; Thompson A; Doyle J; Pattison P; Robins G
Int J Drug Policy; 2015 Oct; 26(10):958-62. PubMed ID: 26072105
[TBL] [Abstract][Full Text] [Related]
3. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
[TBL] [Abstract][Full Text] [Related]
4. Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland.
Fraser H; Mukandavire C; Martin NK; Goldberg D; Palmateer N; Munro A; Taylor A; Hickman M; Hutchinson S; Vickerman P
Addiction; 2018 Nov; 113(11):2118-2131. PubMed ID: 29781207
[TBL] [Abstract][Full Text] [Related]
5. Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium.
Matheï C; Bourgeois S; Blach S; Brixko C; Mulkay JP; Razavi H; Robaeys G
Acta Gastroenterol Belg; 2016; 79(2):227-32. PubMed ID: 27382943
[TBL] [Abstract][Full Text] [Related]
6. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
Echevarria D; Gutfraind A; Boodram B; Layden J; Ozik J; Page K; Cotler SJ; Major M; Dahari H
Vaccine; 2019 May; 37(19):2608-2616. PubMed ID: 30962092
[TBL] [Abstract][Full Text] [Related]
7. Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.
Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Dhersin JS; Yazdanpanah Y
J Viral Hepat; 2015 Mar; 22(3):213-29. PubMed ID: 25270261
[TBL] [Abstract][Full Text] [Related]
8. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.
Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S
Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.
Hickman M; De Angelis D; Vickerman P; Hutchinson S; Martin NK
Curr Opin Infect Dis; 2015 Dec; 28(6):576-82. PubMed ID: 26524330
[TBL] [Abstract][Full Text] [Related]
10. Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in Tayside, Scotland.
Malaguti A; Byrne CJ; Sani F; Power K; Eriksen A; Dillon JF
Behav Med; 2024; 50(2):130-140. PubMed ID: 36411523
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling.
Buchanan R; Khakoo SI; Coad J; Grellier L; Parkes J
Harm Reduct J; 2017 Jul; 14(1):44. PubMed ID: 28697760
[TBL] [Abstract][Full Text] [Related]
12. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.
Martin NK; Hickman M; Hutchinson SJ; Goldberg DJ; Vickerman P
Clin Infect Dis; 2013 Aug; 57 Suppl 2(Suppl 2):S39-45. PubMed ID: 23884064
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden.
Kågström E; Lannergård A; El Khosht J; Lörelius P; Månflod J; Strömdahl S
Harm Reduct J; 2023 Jun; 20(1):77. PubMed ID: 37328868
[TBL] [Abstract][Full Text] [Related]
14. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
Bruggmann P; Grebely J
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
[TBL] [Abstract][Full Text] [Related]
15. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.
Ruta S; Cernescu C
World J Gastroenterol; 2015 Oct; 21(38):10811-23. PubMed ID: 26478672
[TBL] [Abstract][Full Text] [Related]
16. HCV elimination among people who inject drugs. Modelling pre- and post-WHO elimination era.
Gountas I; Sypsa V; Blach S; Razavi H; Hatzakis A
PLoS One; 2018; 13(8):e0202109. PubMed ID: 30114207
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
[TBL] [Abstract][Full Text] [Related]
18. Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?
Gountas I; Sypsa V; Anagnostou O; Martin N; Vickerman P; Kafetzopoulos E; Hatzakis A
Addiction; 2017 Jul; 112(7):1290-1299. PubMed ID: 28107585
[TBL] [Abstract][Full Text] [Related]
19. Eliminating hepatitis C: The importance of frequent testing of people who inject drugs in high-prevalence settings.
Scott N; Sacks-Davis R; Pedrana A; Doyle J; Thompson A; Hellard M
J Viral Hepat; 2018 Dec; 25(12):1472-1480. PubMed ID: 30047625
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
